Our Efforts to Develop a COVID-19 Vaccine
GET TO KNOW DR. ANNALIESA ANDERSON, HEAD OF BACTERIAL VACCINES
PROFESSOR JOE SCHMITT TALKS TICK-BOURNE ENCEPHALITIS
HOW ARE VACCINES DEVELOPED?
WHAT YOU NEED TO KNOW ABOUT COVID-19
Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies Pfizer Inc. (NYSE: PFE) today announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help provide funding and access to Pfizer’s scientific expertise to ensure continuity of the biotechnology companies’ most promising clinical development programs. “There has never…